Member Info for Alpha-dog

Is this a new announcement? The links I found dated to 2018.

Should the Chinese buy synairgen? Let’s face it; the company stock is cheap as chips. A lot cheaper than any soft/political cost of using interferon and risking patent infringement.

I’m with you Doc. Positivity based entirely on the positive data we have to date. I do recall the good Dr Castro from Kansas, who was very positive on SNG, saying it would be hard for SNG to find its niche in regards time from onset of symptoms, patient subgroup, outpatient or inpatient.
My feeling is that synairgen team were right just after release of the at home phase 2. They suggested that SNG would be best targeted at home for those with breathlessness.
In my mind that is the trial we are really looking for. Antivirals tend to have bigger effect given early. I think the in hospital was just underpowered but the effect size was smaller circa 30% RRR on the whole though again with the intriguing suggestion that the more breathless got bigger effects.
Bottom line I remain positive but it has to be the right trial, in the right circumstances. Omicron is not the right covid for SNG to be tested on- not that many people get breathless, have bad pneumonia or end up in ITUs. It’s tough sitting on big paper losses but I’m optimistic that the therapy works well and if that can be demonstrated then we are all on a huge winner. In the meantime it’s a tough lesson in patience.

https://www.offshorewind.biz/2022/12/05/netherlands-selects-offshore-hydrogen-network-developer/
Big offshore wind development for Gasunie. ITM have provided 1MW electrolyser at Zuidwending salt cavern for Gasunie. Fingers crossed ??

She’ll collaboration in Bangalore clearly not a worldwide partnership.
Ceres SOEC technology would have fitted perfectly in this project.
https://world-nuclear-news.org/Articles/Collaborators-to-develop-SMR-based-hydrogen-produc

There are a lot of similar sells at 20.50. Despite this price is stable/rising slightly. Slightly odd. Are dark forces at play? I’m certainly no expert but seems unusual.

I think Shell’s strategy is diversification. They have worked with ITM (PEM) and ceres power (SOEC). This now adds to that.

Do TES build their own electrolysers?

I know this board likes a bit of science. Big role here even in omicron for interferon based therapeutics.
https://amp.scmp.com/news/china/science/article/3201027/omicron-subvariant-ba2-replicates-faster-brain-cells-other-strains-study-finds

I wonder if it is a NEL alkaline electrolysis unit?
I think ITM problems with production, supply chain and also that 5 MW system isn’t yet fully functional are the issues here.
It’s been very hard on the SP but I think these fundamentals need to be in place before significant orders will come through. £1 broken briefly but any chance of recovery to even Feb levels is dependent on these issues being sorted. I am somewhat relieved (with the benefit of hindsight) that these are being prioritised over the second gigafactory. It’s possible New South Wales may make an offer ITM can’t refuse to build there instead.

https://www.npr.org/sections/health-shots/2022/11/20/1137892932/monoclonal-antibodies-covid-treatment
There is definitely a mood swing among top scientists away from monoclonals. SNG represents a paradigm shift in antiviral therapy. Synairgen are working tirelessly to shift the consensus view.

https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON422
No major signs or suggestion of outbreak but one to watch.
Early on in the pandemic there were some concerns about co-infections of MERS and SARS covid 19 leading to a hybrid. So far no sign of this but certainly something the WHO are watching closely.

Thanks Wigster. I thought I was losing it!

Ignore this. Must be my browser.

The conversation about trial in Canada involving University of Southampton has disappeared along with all other posts from today. Any reason?

Great work.

https://www.kallanish.com/en/news/power-materials/market-reports/article-details/volkswagen-group-looks-at-sofc-to-power-potential-fcev-model-1122/
VW appear to be exploring SOFC for FCEV. Hopefully Weichai too.

Investors, like the wider public, are tired of covid and consequently the share price languishes despite solid positive news from synairgen. The bigger question is whether or not there are further twists in the covid tale. Omicron stopped ACTIV2 and OP investigation. Pi, should it arise may determine Synairgen’s future.
This article takes a balanced and scientific view of what is around the corner.
https://www.telegraph.co.uk/global-health/science-and-disease/why-pi-next-covid-variant-every-scientists-lips/

I agree. Very surprised if it works.

European Parliament has confirmed plans for Hydrogen infrastructure across Europe to support hydrogen use in transport. Extract below.
“A maximum distance of 100km between each hydrogen refuelling station, along both the core and comprehensive TEN-T networks, will mean that by the time the infrastructure is in place by end of 2027, up to 1,780 HRS could be available across Europe”
https://hydrogen-central.com/members-european-parliament-have-decided-support-hydrogen-based-green-transition-transport-sector/